Phase Genomics

📊Easy bioinformatics for cytogenetic data curation is here! We are thrilled to announce CytoTerra® Curator is now available for CytoTerra platform users. Effortlessly review, revise, and generate reports from your cytogenetic data – no prior bioinformatics experience required. Stay ahead in your research with faster, more accurate insights. Explore how Curator transforms your data curation process using the link below. 👇 #cytogenetics #data #bioinformatics #datacuration #dataplatform

🦠 Antimicrobial resistance is hitting the coasts In recent article, Jasmine Hagan discusses the rising threat of #AMR on humans, agriculture, and the environment. Focusing on coastal ecosystems, she illuminates the emerging hazards and technologies that could prevent calamity. 🌊 Coastal microbial communities face threats from sewage and wastewater, enhancing the spread of ARGs through mechanisms like horizontal gene transfer, raising urgent questions about the extent and methods of ARG proliferation in such environments. 🧫 Traditional culture-dependent methods fall short in revealing full microbial diversity, missing unculturable bacteria. Culture-independent methods like ProxiMeta can significantly enhance our understanding of microbial communities – including mobile genetic elements. 🔬 Studies using this technology trace ARGs to their hosts in complex environments – not only identifying ARG reservoirs, but tracking horizontal gene transfer, crucial for understanding antibiotic resistance spread and providing the blueprints for future efforts. 🌍 The World Health Organization's #OneHealth approach integrates human, animal, and environmental health strategies to combat AMR. By understanding environmental AMR, we can develop targeted strategies to mitigate the spread of drug resistance, offering hope for sustaining coastal and global health. 📚 Dive deeper into the fight against AMR in coastal ecosystems in Hagan’s article (link in comments).

An unexpected, but excellent, write-up on our #microbiome sequencing technology and why it's very useful in tracking and combatting #AMR . https://lnkd.in/gxnrznRh

“We’re assembling genomes for plants and animals… detecting new cancer fusion rearrangements… killing methane-producing bacteria in cows, but it all comes from the same place” On Biotech CEO Stories, Ivan Liachko 🇺🇦 discusses the breadth of applications supported by Phase Genomics’ ultra-long-range sequencing technology with Timothy Dougherty. Listen in to discover the story behind commercializing and implementing biotech innovations and get a glimpse at where this technology is taking us. From scaffolding genomes to stopping superbugs, Ivan details the path to a healthier future. 💡 Want to know more? Tune into this week’s episode using the link below or catch David Shoultz at this week’s BIO Investor Forum. #genome #therapeutics #oncology #sciencepodcast #biotech #drugdiscovery https://lnkd.in/ewqh-YwF

What was it like spinning off a startup having been in academic for 20 years? What is long range sequencing, in DNA sequencing, and why does it matter in decoding the genome? Our guest today is Ivan Liachko 🇺🇦 the CEO of Seattle-based Phase Genomics, a company whose core technology is ultra-long range genome sequencing. For full show, see link in comments field.

From detecting novel #cancer biomarkers to discovering new avenues in #therapeutics, a lot is happening at Phase Genomics and we would love to keep you in the loop! If you haven’t signed up for Phasebook, now is the time. Read our Fall newsletter today: https://lnkd.in/g_NABxJb 

New tech and next steps – Phase Genomics announces new data curation platform and advances therapeutic endeavors. Read more in this Fall's edition of Phasebook 👇

Phase Genomics welcomes its first Chief Business Officer, David Shoultz, PhD, MBA, to drive growth and amplify the impact of technological innovation at the frontiers of human health. David’s diverse experience leading companies in global health and therapeutics perfectly aligns with our mission to bring about a healthier future. Join us in welcoming him to the team! Learn more about David and Phase Genomics’ path forward in the link below 👇

🔎 Simultaneously detect all major types of genomic rearrangements that cause and characterize #cancer on a genome-wide scale. Cytogenetics tool, CytoTerra, comprehensively surveys the genomic landscape from a wide variety of biological samples. Here’s how… Enabled by Genomic Proximity Mapping™, CytoTerra provides a high-resolution view of translocations and inversions, as well as copy number variants (CNVs), using a single NGS-based assay and cloud-based analysis platform. Discover more in the link below 👇

Mark your calendars! Join Ivan Liachko 🇺🇦 today at #LAMG2024 for a presentation on how #phage-host interaction data could be the key to tackling #AMR, advancing phage therapy, and protecting the globe from biothreats.